Thoratec (NASDAQ: THOR), known for its ventricular assist devices (VADs) for patients suffering late-stage heart failure, recently bought Australia's HeartWare. Investors responded positively to this move because it brings new technology to Thoratec and expands the company's already significant market share.
THOR currently has 85% of the U.S. heart pump market and 65% of Europe's, and this new technology could ensure THOR stays on the top of this market for at least the next five to 10 years. The Thoratec-HeartWare partnership has the potential to grow into a multibillion-dollar business, which will translate to big sales and earnings growth.
After reporting earnings last week, the company said that strong sales at its cardiovascular division drove revenue up 39% over last year to $89.6 million, and earnings rose to $5.6 million or 22 cents per share, compared with a net loss of $678,000 or one cent per share in the first quarter of 2008. Analysts were expecting earnings of 16 cents per share on revenue of $82.9 million, so Thoratec posted a 37.5% earnings surprise and a 7.5% sales surprise. Thoratec has great fundamentals and is a phenomenal buy.
Click here for the complete list of Small-Cap Stocks to Buy Now.
And for more top stocks to buy and sell, check out:
Closing Bell: When We All Love the PIIGS (NBG, SQNM, PG, ERTS, KO)
Serious Money: Cheapest Stocks List Shrinks from 26 to 21
Chasing Value: Hasbro Earnings Makes My Point
Reader Comments (Page 1 of 1)
5-18-2009 @ 3:48AM
moremony2 said...
Moremony services is a leading company for Affiliate marketing ,Seo services,Website development Internet marketing.http://www.moremony.com